Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126627132 | 12662713 | 2 | F | 20160811 | 20160818 | 20160823 | EXP | US-APOTEX-2016AP010392 | APOTEX | GAJUREL K, GOMEZ CA, DHAKAL R, VOGEL H, MONTOYA JG.. FAILURE OF PRIMARY ATOVAQUONE PROPHYLAXIS FOR PREVENTION OF TOXOPLASMOSIS IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS.. TRANSPL-INFECT-DIS. 2016;18(3):446-452 | 70.00 | YR | M | Y | 0.00000 | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126627132 | 12662713 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | UNK | U | U | 90499 | TABLET | |||||||
| 126627132 | 12662713 | 2 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | UNK | U | U | 0 | CAPSULE | |||||||
| 126627132 | 12662713 | 3 | SS | ANTITHYMOCYTE IMMUNOGLOBULIN | THYMOCYTE IMMUNE GLOBULIN NOS | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126627132 | 12662713 | 4 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | 0 | ||||||||||
| 126627132 | 12662713 | 5 | C | ACICLOVIR | ACYCLOVIR | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126627132 | 12662713 | 6 | C | ATOVAQUONE. | ATOVAQUONE | 1 | Unknown | 1500 MG, T.I.W | U | U | 0 | 1500 | MG | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126627132 | 12662713 | 1 | Prophylaxis against graft versus host disease |
| 126627132 | 12662713 | 2 | Prophylaxis against graft versus host disease |
| 126627132 | 12662713 | 3 | Stem cell transplant |
| 126627132 | 12662713 | 4 | Prophylaxis |
| 126627132 | 12662713 | 5 | Prophylaxis |
| 126627132 | 12662713 | 6 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126627132 | 12662713 | HO |
| 126627132 | 12662713 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126627132 | 12662713 | Cytomegalovirus colitis | |
| 126627132 | 12662713 | Cytomegalovirus viraemia | |
| 126627132 | 12662713 | Drug ineffective | |
| 126627132 | 12662713 | Graft versus host disease | |
| 126627132 | 12662713 | Toxoplasmosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |